Burden of gastrointestinal disease in U.S. substantial

October 29, 2012
Burden of gastrointestinal disease in U.S. substantial
Gastrointestinal diseases account for substantial morbidity, mortality, and cost in the United States, according to research published in the November issue of Gastroenterology.

(HealthDay)—Gastrointestinal diseases account for substantial morbidity, mortality, and cost in the United States, according to research published in the November issue of Gastroenterology.

Anne F. Peery, M.D., from the University of North Carolina in Chapel Hill, and colleagues reviewed data on the epidemiology of collected from the National Ambulatory Medical Care Survey; National Health and Wellness Survey; Nationwide Inpatient Sample; Surveillance, Epidemiology, and End Results Program; National Vital Statistics System; Thompson Reuters MarketScan; Medicare; Medicaid; and the Clinical Outcomes Research Initiative's National Endoscopic Database. Endoscopic use, costs, and trends were examined.

The researchers found that the most common gastrointestinal symptom prompting a clinic visit was abdominal pain (15.9 million visits) and the most common gastrointestinal diagnosis was gastroesophageal reflux (8.9 million visits). In the last 10 years, hospitalizations and mortality from Clostridium difficile infection doubled. The most common reason for hospitalization (274,119 discharges) was acute pancreatitis. Colorectal cancer was the leading cause of gastrointestinal-related mortality (52,394 deaths) and accounted for more than half of all . In 2009 there were 6.9 million upper, 11.5 million lower, and 228,000 biliary endoscopies performed, with total costs of $32.4 billion for outpatient gastrointestinal endoscopy examinations.

"In summary, we present a comprehensive and current estimate of the toll of gastrointestinal and in the United States," the authors write. "Payers, policy makers, clinicians, and others interested in resource utilization may use these statistics to better understand evolving disease trends and the best way to meet the challenge of these diseases."

Explore further: Death from GI bleeding decreased in United States in past two decades

More information: Abstract
Full Text

Related Stories

Death from GI bleeding decreased in United States in past two decades

October 22, 2012
The number of patients dying from upper gastrointestinal bleeding has decreased over the past two decades, a result researchers attribute to the advances in medical and endoscopic therapies introduced over the past 20 years, ...

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.